Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Cash from Operations (2016 - 2025)

Traws Pharma (TRAW) has disclosed Cash from Operations for 14 consecutive years, with 2758000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations rose 31.73% year-over-year to 2758000.0; the TTM value through Dec 2025 reached 18185000.0, up 38.96%, while the annual FY2025 figure was 18185000.0, 38.96% up from the prior year.
  • Cash from Operations hit 2758000.0 in Q4 2025 for Traws Pharma, up from 4011000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2758000.0 in Q4 2025 and bottomed at 11476000.0 in Q3 2024.
  • Average Cash from Operations over 5 years is 5084500.0, with a median of 4365500.0 recorded in 2021.
  • Year-over-year, Cash from Operations plummeted 156.79% in 2024 and then surged 65.05% in 2025.
  • Traws Pharma's Cash from Operations stood at 4265000.0 in 2021, then increased by 8.93% to 3884000.0 in 2022, then decreased by 14.06% to 4430000.0 in 2023, then rose by 8.8% to 4040000.0 in 2024, then soared by 31.73% to 2758000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 2758000.0, 4011000.0, and 5979000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.